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Acute septic thrombophlebitis of the internal jugular vein (IJV), better known as Lemierre syndrome, is a rare entity which
poses several challenges in management. Treatment involves prompt use of intravenous antibiotics over a prolonged period of
time, typically 6–8 weeks. The use of anticoagulation is controversial, but indicated for some. We describe the ﬁrst reported
case of Lemierre syndrome associated with a hypercoagulable state in an adult. We propose that all patients with Lemierre
syndrome should be evaluated for hypercoagulable states and that the indications for anticoagulation in Lemierre syndrome are
(1) propagation or nonresolution of IJV thrombus despite antibiotics and (2) identiﬁcation of a hypercoagulable state, as in our
case.
1.Introduction
Lemierre syndrome is caused by an acute oropharyngeal
infection leading to secondaryseptic thrombosis of the inter-
nal jugular vein. The clinical presentation is characteristic,
and a cure is possible in most cases with antibiotic ther-
apy. The prevalence of hypercoagulable states in Lemierre
syndrome is unknown, with only a few cases reported in
pediatric literature. Also, there are no clear indications for
use of anticoagulation. We describe the ﬁrst reported case of
Lemierre syndrome associated with a hypercoagulable state
in an adult.
2.CaseReport
A previously healthy 18-year-old female, presented with sore
throat and high grade fever. She further developed pleuritic
chest pain, dyspnea and became hypotensive requiring vaso-
pressors. Her examination was signiﬁcant for left-sided neck
tenderness and edema and an enlarged left tonsil without
exudates. Initial laboratory investigations revealed leukocy-
tosis with a left shift. CT scan of the neck showed extensive
thrombus in the left internal jugular vein (IJV) extending
from midthyroid to base of the skull (see Figure 1(a)).
The left palatine tonsil had serpentine enhancement with
extensive parapharyngeal inﬂammation. CT thorax showed
bilateral pleural eﬀusion (see Figure 1(b)) and multiple
septic emboli (see Figures 1(c) and 1(d)). The eﬀusions
were exudative and parapneumonic on thoracentesis. Blood
cultures were positive for Streptococcus Groups C and G,
both of which were penicillin sensitive. After the cultures
returned, she was changed from broad spectrum antibiotics
tointravenouspenicillinGcontinuousinfusionandmetron-
idazole. Because of the persistent left IJV thrombosis despite
adequate antibiotics, she was started on intravenous unfrac-
tionated heparin. Upon clinical improvement, vasopressors
were gradually weaned oﬀ, and heparin was transitioned
to warfarin to keep the International Normalization Ratio
(INR) above 2.
At the time of diagnosis, she had a thrombophilia
screen revealing a heterozygosity for factor V Leiden (FVL)
mutation (R506Q, with no haplotype of Factor V HR2 or
Cambridge mutations seen) and had a positive Lupus Anti-
coagulant(LAC)panel(seeTable 1).Atthetimeofdischarge,2 Case Reports in Medicine
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Figure 1: Neck CT scan (a) with contrast reveals left IJV thrombosis noted by the arrow. Chest CT scan reveals bilateral eﬀusions (b) and
multiple septic emboli (c and d).
metronidazole was stopped, and penicillin was continued
intravenously at home via a peripherally inserted central
catheter (PICC) for a total duration of 6 weeks. Followup
CT scan showed that IJV remained occluded, but septic
pulmonary emboli had resolved with no residual cavities.
The repeat LAC panel during followup had remained weakly
positive (see Table 1). She continues on warfarin and will be
evaluated every three months with a LAC panel and repeat
CT scan of neck for consideration to stop anticoagulation.
3. Discussion
Septic thrombophlebitis of IJV also known as Lemierre
syndrome typically presents in healthy teenagers and young
adults. The causative organism is usually Fusobacterium
necrophorum; however, other causative organisms such as
Streptococcus (as in our case) can be found [1]. The
pathogenesis involves spread of infection from peritonsillar
tissueintolateralparapharyngealspacevialymphaticvessels.
Infection of this compartment can cause complications such
as thrombophlebitis of IJV and severe sepsis with metastatic
infections, including the lungs (septic pulmonary embolism,
cavitating pneumonia) and bones (septic osteomyelitis,
septic arthritis). The mainstay of treatment is prompt use
of intravenous antibiotics over prolonged period of time,
typically 6–8 weeks. Commonly used antibiotics include
penicillin, clindamycin and metronidazole.
The prevalence of hypercoagulable states associated with
Lemierre syndrome in adults is unknown. There are case
reports in children which point to hypercoagulable associ-
ations with other forms of suppurative thrombophlebitis.
One study showed that ﬁve of seven children with acute
otitis media associated with venous sinus thrombosis had
thrombophilias, including elevated lipoprotein apolipopro-
tein, antibodies to beta 2-glycoprotein, heterozygous FVL
mutation, and homozygous methyltetrahydrofolate reduc-
tase (MTHFR) mutation [2]. Other studies have found
transientelevationsinantiphospholipidantibodiesafterviral
infectionsinchildrensuggestinganinducedhypercoagulable
state associated with infectious processes [3]. There is one
case report of a child with Lemierre syndrome in association
with prothrombin gene mutation, an elevated lipoproteinCase Reports in Medicine 3
Table 1: Thrombophilia screen.
Day 4 Day 80 Normal value Units
PT 17.4 46.4 11–15 seconds
APTT 62.4 47 22–35 seconds
PTT mix 38.5 38.7 28–38 seconds
Thrombin time 76.9 22.9 16–22 seconds
Reptilase time 17.6 14–18 seconds
Protein C activity 17 <10 70–140 percent
Protein S activity 68 <10 58–128 percent
Factor V HR2 ND ND — —
Factor V L M HZ HZ — —
Factor VIII 2.01 1.05 0.6–1.5 Units/mL
Factor X 0.78 0.1 0.7–1.5 Units/mL
Dil RVVT 1.4 — 0.9–1.3 ratio
A T III activity 46 97 80–120 percent
HLN Pos Neg — —
TTI 1.7 2.2 0.7–1.3 ratio
d APC R 1.8 1.6 2.1–30 ratio
ACL IgG 13.3 11.9 0.0–23 GPL units
ACL IgM 17 8.2 0.0–11 MPL units
apolipoprotein and a carrier MTHFR mutation [4]. In our
patient, we found an inherited thrombophilia (FVL muta-
tion, heterozygous) and an induced hypercoagulable state, a
positive LAC panel which persisted for months after initial
presentation. The prevalence of FVL and antiphospholipid
antibodies in the general population is reported as less than
seven percent for both of these conditions [5]. Given that the
incidence of Lemierre syndrome is rare, one case per million
p o p u l a t i o np e ry e a rb yo n ee s t i m a t e[ 6], the association of a
hypercoagulable state with Lemierre syndrome is less likely
random, and a hypercoagulable state may be a potential risk
factor for Lemierre syndrome.
The role of anticoagulation in Lemierre syndrome is
controversial. Case reports and series in other forms of septic
thrombophlebitis support the use of anticoagulation. In
threecaseseriesofpatientswithpelvicveinthrombophlebitis
who failed antibiotic treatment alone, addition of heparin
after four to ﬁve days of antibiotic use showed defervescence
of fever [7]. In another case series, three of six patients with
catheter-related central vein septic thrombophlebitis were
successfully treated with removal of catheter, antibiotics, and
anticoagulation [8].
Although no clinical trials exist to examine the role for
anticoagulationinLemierresyndrome,weproposethatthere
are at least two potential indications for anticoagulation in
Lemierre syndrome. First, we believe that propagation or
nonresolution of the thrombus despite antibiotics is an abso-
lute indication for anticoagulation. One case report showed
reduced neurological sequelae seen when anticoagulation
was used to treat suppurative cavernous sinus thrombosis
in a patient with retrograde propagation from the sigmoid
sinus [9]. Second, we believe that anticoagulation should be
administered to all patients with any form of predisposing
thrombophilia, such as in our patient. Given the rarity of
Lemierre syndrome and the impact of correctly identifying
a hypercoagulable state, we feel that the possibility of under-
lying thrombophilia shouldbe exploredin everypatient with
Lemierre syndrome to consider anticoagulation. Because we
have no overwhelming evidence to date, anticoagulation in
Lemierre syndrome should be considered on an individual
basis after weighing the risks and beneﬁts.
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Abbreviations
PT: Prothrombin time
APTT: Activated partial thromboplastin time
PTT mix: Partial thromboplastin time mixed
study
Factor V HR2: Haplotype of factor V gene
F a c t o rVLM : F a c t o rVL e i d e nm u t a t i o n
HZ: Heterozygous
Dil RVVT Diluted Russel viper venom time
HLN: Hexagonal lipid neutralization test
TTI: Tissue thromboplastin Index
d APC R: d activated protein C resistance
ACL: Anticardiolipin antibody.4 Case Reports in Medicine
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